山东大学耳鼻喉眼学报 ›› 2026, Vol. 40 ›› Issue (3): 1-6.doi: 10.6040/j.issn.1673-3770.0.2025.141

• 论著 •    下一篇

糖皮质激素通过下调水通道蛋白2缓解精氨酸加压素诱导的膜迷路积水

李梦欣1,2,3,徐慧4,张晓玲1,2,3,5,薛晴1,2,3,5,纪霜钰1,2,3,李莹莹6,崔丽梅1,2,3,郭兆剑7,宋西成1,2,3,孙岩1,2,3,陈良1,2,3   

  1. 1.青岛大学附属烟台毓璜顶医院 耳鼻咽喉头颈外科, 山东 烟台 264099;
    2.山东省耳鼻喉疾病临床医学研究中心, 山东 烟台 264099;
    3.烟台市 耳鼻喉疾病重点实验室, 山东 烟台 264099;
    4.青岛大学附属烟台毓璜顶医院 口腔科, 山东 烟台 264099;
    5.滨州医学院第二临床医学院, 山东 烟台 264030;
    6.阜阳市肿瘤医院, 安徽 阜阳 236001;
    7.青岛大学附属烟台毓璜顶医院 病理科, 山东 烟台 264099
  • 发布日期:2026-05-22
  • 通讯作者: 陈良. E-mail:entchenliang@hotmail.com
  • 基金资助:
    国家自然科学基金项目(#82371153);山东省自然科学基金项目(#ZR2021MH378);烟台毓璜顶医院基金项目(FZ202401)

Glucocorticoids alleviate endolymphatic hydrops induced by arginine vasopressin by downregulating aquaporin-2

LI Mengxin1,2,3, XU Hui4, ZHANG Xiaoling1,2,3,5, XUE Qing1,2,3,5, JI Shuangyu1,2,3, LI Yingying6, CUI Limei1,2,3,   

  1. GUO Zhaojian7, SONG Xicheng1, 2, 3, SUN Yan1, 2, 3, CHEN Liang1, 2, 31. Department of Otorhinolaryngology & Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264099, Shandong, China2. Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai 264099, Shandong, China3. Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai 264099, Shandong, China4. Department of Stomatology, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264099, Shandong, China5. The Second Medical College of Binzhou Medical University, Yantai 264030, Shandong, China6. Fuyang Cancer Hospital, Fuyang 236001, Anhui, China7. Department of Pathology, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264099, Shandong, China
  • Published:2026-05-22

PDF (PC)

6

摘要： 目的 探讨糖皮质激素对精氨酸加压素诱导的膜迷路积水大鼠的治疗作用及其与水通道蛋白2(aquaporin-2, AQP2)表达调控的关联。 方法 将Wistar大鼠随机分为4组:对照组(生理盐水)、造模组(醋酸去氨加压素)、地塞米松干预组(DXM组)及地塞米松联合米非司酮干预组(DXM + RU486组)。采用HE染色观察耳蜗组织膜迷路积水程度,计算中阶面积与中阶、前庭阶面积之和的比值(R值)进行量化;免疫组化检测AQP2蛋白在耳蜗中的分布与表达;qRT-PCR检测AQP2 mRNA表达水平。 结果 造模组较对照组出现明显膜迷路积水(P<0.01),耳蜗AQP2 mRNA及蛋白表达水平均显著升高(P<0.05)。DXM组积水程度较造模组减轻(P<0.05),AQP2表达水平下降(P<0.05)。DXM+RU486组积水程度及AQP2表达均较DXM组显著增加(P<0.001)。免疫组化显示AQP2广泛表达于血管纹(stria vascularis, SV)、螺旋韧带(spiral ligament, SL)、螺旋器(organ of Corti, OC)、前庭膜及螺旋神经节,且定位于细胞膜。SV与SL中AQP2表达变化与积水程度一致;OC中DXM组AQP2表达虽下降但差异无统计学意义。 结论 糖皮质激素可能通过下调耳蜗中AQP2的表达缓解精氨酸加压素诱导的膜迷路积水,其作用与SV、SL等部位AQP2的调控密切相关,该效应可被糖皮质激素受体拮抗剂米非司酮部分逆转。

关键词: 糖皮质激素, 膜迷路积水, 水通道蛋白2

Abstract: Objective To investigate the therapeutic effect of glucocorticoids on arginine vasopressin(AVP)-induced endolymphatic hydrops(ELH)in rats and its association with the regulation of aquaporin-2(AQP2)expression. Methods Wistar rats were randomly divided into four groups: control(normal saline), model(desmopressin acetate), dexamethasone(DXM)intervention, and DXM + mifepristone(RU486)intervention groups. Cochlear tissues were collected for hematoxylin-eosin staining to assess the degree of ELH, quantified by the ratio(R value)of the scala media area to the sum of scala media and scala vestibuli areas. Immunohistochemistry was performed to analyze the distribution and expression of AQP2 protein in the cochlea, and qRT-PCR was used to detect AQP2 mRNA expression levels. Results Compared with the control group, the model group showed significant ELH(P<0.01)and markedly increased AQP2 mRNA and protein expression(P<0.05). The DXM group exhibited reduced ELH(P<0.05)and decreased AQP2 expression(P<0.05)compared with the model group. In the DXM+RU486 group, both ELH severity and AQP2 expression were significantly higher than those in the DXM group(P<0.001). Immunohistochemistry revealed widespread AQP2 expression in the stria vascularis(SV), spiral ligament(SL), organ of Corti(OC), Reissner's membrane, and spiral ganglion neurons, with predominant localization to the cell membrane. Changes in AQP2 expression in the SV and SL were consistent with the degree of hydrops. In the OC, although AQP2 expression decreased in the DXM group, the difference was not statistically significant. Conclusion Glucocorticoids may alleviate AVP-induced ELH by downregulating AQP2 expression in the cochlea, particularly in the SV and SL. This effect can be partially reversed by the glucocorticoid receptor antagonist mifepristone.

Key words: Glucocorticoid, Endolymphatic Hydrops, Aquaporin-2

中图分类号: 

  • R764
[1] Hallpike CS, Cairns H. Observations on the pathology of ménière's syndrome:(section of otology)[J]. Proc R Soc Med, 1938, 31(11): 1317-1336. doi: 10.1177/003591573803101112
[2] Pender DJ. Meniere's disease: Structural considerations in early cochlea Hydrops[J]. Laryngoscope Investig Otolaryngol, 2024, 9(6): e70041. doi:10.1002/lio2.70041
[3] Thulasiram MR, Ogier JM, Dabdoub A. Hearing function, degeneration, and disease: spotlight on the stria vascularis[J]. Front Cell Dev Biol, 2022, 10: 841708. doi:10.3389/fcell.2022.841708
[4] Huang C, Wang Q, Pan XY, et al. Up-regulated expression of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in the endolymphatic sac of Meniere's disease suggesting the local inflammatory response underlies the mechanism of this disease[J]. Front Neurol, 2022, 13: 781031. doi:10.3389/fneur.2022.781031
[5] Kim SH, Kim JY, Lee HJ, et al. Autoimmunity as a candidate for the etiopathogenesis of Meniere's disease: detection of autoimmune reactions and diagnostic biomarker candidate[J]. PLoS One, 2014, 9(10): e111039. doi:10.1371/journal.pone.0111039
[6] Egami N, Kakigi A, Takeda T, et al. Type 1 allergy-induced endolymphatic Hydrops and the suppressive effect of H1-receptor antagonist(olopatadine hydrochloride)[J]. Otol Neurotol, 2014, 35(3): 104-109. doi: 10.1097/mao.0000000000000195
[7] Das S, Bakshi SS, Seepana R. Demystifying autoimmune inner ear disease[J]. Eur Arch Otorhinolaryngol, 2019, 276(12): 3267-3274. doi: 10.1007/s00405-019-05681-5
[8] Sajjadi H, Paparella MM. Meniere's disease[J]. Lancet, 2008, 372(9636): 406-414. doi: 10.1016/S0140-6736(08)61161-7
[9] Xue Q, Xing WW, Liu YX, et al. Effects of intratympanic injection of dexamethasone on endolymphatic Hydrops and changes in guinea pigs inner ear CFTR expression[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(19): 1483-1486. doi: 10.13201/j.issn.1001-1781.2014.19.009
[10] Takeda T, Takeda S, Kakigi A, et al. Hormonal aspects of Ménière's disease on the basis of clinical and experimental studies[J]. ORL J Otorhinolaryngol Relat Spec, 2010, 71(1): 1-9. doi: 10.1159/000265113
[11] Maekawa C, Kitahara T, Kizawa K, et al. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere's disease[J]. J Neuroendocrinol, 2010, 22(11): 1157-1164. doi: 10.1111/j.1365-2826.2010.02060.x
[12] Gu FM, Han HL, Zhang LS. Effects of vasopressin on gene expression in rat inner ear[J]. Hear Res, 2006, 222(1/2): 70-78. doi: 10.1016/j.heares.2006.08.016
[13] Luo Y, Zhang DG, Chen YL, et al. Dexamethasone protects against arsanilic acid-induced rat vestibular dysfunction through the BDNF and JNK 1/2 signaling pathways[J]. Mol Med Rep, 2019, 19(3): 1781-1790. doi: 10.3892/mmr.2019.9835
[14] 张斯, 王林娥, 刘攀, 等. 圆窗膜挑开前后豚鼠听功能变化研究[J]. 中国听力语言康复科学杂志, 2024, 22(4): 433-437, 446. doi: 10.3969/j.issn.1672-4933.2024.04.024 ZHANG Si, WANG Line, LIU Pan, et al. Effect of opening round window membrane on auditory function of healthy guinea pigs[J]. Chinese Scientific Journal of Hearing and Speech Rehabilitation, 2024, 22(4): 433-437, 446. doi: 10.3969/j.issn.1672-4933.2024.04.024
[15] Jiang LY, He JJ, Chen XX, et al. Arginine vasopressin-aquaporin-2 pathway-mediated dehydration effects of electroacupuncture in guinea pig model of AVP-induced eendolymphatic Hydrops[J]. Chin J Integr Med, 2019, 25(10): 763-769. doi: 10.1007/s11655-017-2411-2
[16] Lundquist P G, Kimura R, Wersaell J. Experiments in endolymph circulation[J]. Acta Otolaryngol Suppl, 1964, 188: 198. doi: 10.3109/00016486409134562
[17] Takeda T, Takeda S, Kakigi A. A possible mechanism of the formation of endolymphatic Hydrops and its associated inner ear disorders[J]. Auris Nasus Larynx, 2020, 47(1): 25-41. doi: 10.1016/j.anl.2019.09.005
[18] Sun SJ, Zhang DG, Sun GY, et al. Solute carrier family 4 member 1 might participate in the pathogenesis of Meniere's disease in a murine endolymphatic hydrop model[J]. Acta Oto Laryngol, 2019, 139(11): 966-976. doi: 10.1080/00016489.2019.1663365
[19] Nishioka R, Takeda T, Kakigi A, et al. Expression of aquaporins and vasopressin type 2 receptor in the stria vascularis of the cochlea[J]. Hear Res, 2010, 260(1/2): 11-19. doi: 10.1016/j.heares.2009.09.011
[20] Frejo L, Gallego-Martinez A, Requena T, et al. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease[J]. Sci Rep, 2018, 8(1): 5974. doi:10.1038/s41598-018-23911-4.doi: 10.1038/s41598-018-23911-4
[21] Sato A, Omichi R, Maeda Y, et al. A glucocorticoid-regulating molecule, Fkbp5, may interact with mitogen-activated protein kinase signaling in the organ of Corti of mice cochleae[J]. Sci Rep, 2025, 15: 7506. doi:10.1038/s41598-025-92400-2
[22] 廖行伟, 任毅, 黄巧, 等. P38MAPK调控AQP2参与内淋巴积水的形成[J]. 中华耳科学杂志, 2022, 20(4): 605-611. doi: 10.3969/j. issn.1672-2922.2022.04.013 LIAO Xingwei, REN Yi, HUANG Qiao, et al. P38MAPK participates in formation of endolymphatic Hydrops by regulating AQP2[J]. Chinese Journal of Otology, 2022, 20(4): 605-611. doi: 10.3969/j. issn.1672-2922.2022.04.013
[23] Gao ZW, Schwieger J, Matin-Mann F, et al. Dexamethasone for inner ear therapy: biocompatibility and bio-efficacy of different dexamethasone formulations in vitro[J]. Biomolecules, 2021, 11(12): 1896. doi:10.3390/biom11121896
[24] Johns JD, Adadey SM, Hoa M. The role of the stria vascularis in neglected otologic disease[J]. Hear Res, 2023, 428: 108682. doi:10.1016/j.heares.2022.108682
[25] Terakado M, Kumagami H, Takahashi H. Distribution of glucocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase isoforms in the rat inner ear[J]. Hear Res, 2011, 280(1/2): 148-156. doi: 10.1016/j.heares.2011.05.00
[26] Froehlich MH, Lambert PR. The physiologic role of corticosteroids in menière's disease: an update on glucocorticoid-mediated pathophysiology and corticosteroid inner ear distribution[J]. Otol Neurotol, 2020, 41(2): 271-276. doi: 10.1097/mao.0000000000002467
[27] Inagaki K, Yoshida T, Kobayashi M, et al. Impact of endolymphatic Hydrops on DPOAE in subjects with normal to mild hearing loss[J]. Laryngoscope Investig Otolaryngol, 2022, 8(1): 262-268. doi: 10.1002/lio2.998
[28] Liang JY, Wang JK, Yao WJ. Hearing loss caused by hair cell lesions[J]. IEEE Trans Biomed Eng, 2025, 72(8): 2544-2554. doi: 10.1109/TBME.2025.3547059
[1] 段思妤,薛金梅. 组蛋白去乙酰化酶2在慢性气道炎症性疾病糖皮质激素抵抗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 120-126.
[2] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[3] 曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[4] 王振晓,时光刚,何明强,时蕾. 哮吼患者的治疗选择和管理策略[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 136-144.
[5] 陈兴雪,张广玲,武天义,王卫卫,孙占伟,李世超,王广科. 抗IL-4Rα单克隆抗体与鼻内镜手术治疗嗜酸性粒细胞型慢性鼻窦炎伴鼻息肉的疗效分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 43-54.
[6] 李淑婷,赵慧,司明威,崔文轩,杨梦瑶,王红. 无植物性外伤史患者感染真菌性眼内炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 103-108.
[7] 王丽雪,曾毅,王丽欣,彭先兵. 浸润毕罗芬明胶海绵在功能性鼻内镜鼻窦手术后应用效果的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 16-25.
[8] 李聪,李玲,刘亭彦, 陈良. 氨基糖苷类抗生素耳毒性影响因素研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 128-134.
[9] 王茜,刘娜,王少鹏. Leber特发性星芒状视神经视网膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 106-110.
[10] 资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103.
[11] 陈世琴,卫平存,胡云龙,胡金旺. 糖皮质激素三种不同鼻用法对鼻内镜术后黏膜转归的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 195-201.
[12] 姜洋,李莹,崔歌. 0.1%双氯芬酸钠滴眼液在SMILE术后疗效的观察[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 57-60.
[13] 张俊军,刘海莉,刘加福,秦小奉,杜洪明,王厚慧. 糖皮质激素不同给药方式治疗突发性聋的临床疗效及安全性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 52-55.
[14] 黄巧,尹时华. 内耳上皮钠通道、水通道蛋白与内淋巴代谢相关性的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 145-148.
[15] 刘建波,张环. 超声乳化联合玻璃体腔药物注射治疗白内障合并糖尿病性黄斑水肿[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 99-104.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发